NADIA LOZANO: Open Payments
NPI 1023688645 · HARLINGEN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,126 in 29 payments from 10 companies in 2025. Trend: 2023 $509 · 2024 $644 · 2025 $1,126
Food & beverage: $1,126
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 4 | $262 |
| Ardelyx, Inc. | 4 | $161 |
| Phathom Pharmaceuticals, Inc. | 2 | $154 |
| Madrigal Pharmaceuticals | 1 | $137 |
| Boston Scientific Corporation | 1 | $120 |
| Ipsen Biopharmaceuticals, Inc | 6 | $111 |
| ABBVIE INC. | 4 | $65 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $61 |
| Lilly USA, LLC | 2 | $39 |
| Novo Nordisk Inc | 1 | $16 |
Products named: TREMFYA, IBSRELA, VOQUEZNA, REZDIFFRA, Axonics, IQIRVO, XIFAXAN, OMVOH.
Industry payments across TX — which companies pay providers there.
